Gd-Tex: Based on results from a Phase I trial

The trial will include up to 50 patients, 30 of whom will receive 10 escalating doses of the compound over a two-week period prior to radiation, with the highest cumulative doses to be lower than the highest dose in the Phase I trial. ...